ASCO: Mortality High for Cancer Patients With COVID-19
Factors linked to 30-day mortality include age, male sex, smoking status, comorbidities, active cancer
Radiation Oncology Clinic Visits Down Due to COVID-19
Patient volume decreased despite vast majority of practices adopting enhanced safety practices
Insulin Resistance May Add to Racial Disparity in Breast Cancer Prognosis
Tumors from black women with invasive breast cancer have higher expression of the insulin receptor
May 2020 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for May 2020. This roundup includes...
Outcomes Equal for AYA Hodgkin Therapy at Peds, Adult Centers
Treatment strategies differ, but outcomes equivalent among adolescent, young adult Hodgkin patients
Infection Risk Up in Month After CAR T-Cell Immunotherapy
Infection rates increase in patients with ALL aged ≤26 years in first month, then decrease at days 29 to 90
ASCO: Relugolix Superior to Leuprolide in Advanced Prostate Cancer
And, enzalutamide improves median overall survival in nonmetastatic, castration-resistant prostate cancer
9.5 Percent Uninsured in U.S. From January Through June 2019
Overall, 13.7 percent of adults aged 18 to 64, 4.4 percent of children aged 0 to 17 were uninsured
Risk for Later Invasive Breast Cancer Up for Women With DCIS
Risks for invasive breast cancer, death from breast cancer higher for up to 20 years following diagnosis
Links Found Between Leaders of Medical Associations, Industry
Most leaders have ties to industry; considerable variation seen among 10 medical associations in U.S.
